The Food and Drug Administration (FDA) has approved Kisqali, a breast cancer drug designed to treat advanced metastatic cases, for use in patients with earlier stage breast cancer. Novartis, the drug’s manufacturer, said that up to tens of thousands of women with early-stage breast cancer may get a new option that can help prevent their cancer
Loading
All posts in "Cancer News"
Black women have a much lesser breast cancer survival rates than white women, even from types that are typically thought to be treatable.
Black women have a much lesser breast cancer survival rates than white women, even from types that are typically thought to be treatable.
The Food and Drug Administration (FDA) has approved Kisqali, a breast cancer drug designed to treat advanced metastatic cases, for use in patients with earlier stage breast cancer. Novartis, the drug’s manufacturer, said that up to tens of thousands of women with early-stage breast cancer may get a new option that can help prevent their cancer
